All Products

Featured Products

Newest Products

Research Areas

VEGFR Products

or product name starting with: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

KRN633 is a potent and selective VEGFR inhibitor. which inhibits tyrosine phosphor...

Lenvatinib mesylate

Lenvatinib, also known as E7080, is a synthetic, orally available inhibitor of vas...

Lucitanib , also known as E-3810 and AL3810, is a novel dual inhibitor targeting h...

MGCD-265-analog

MGCD265-analog, CAS#875337-44-3, is structurally related to MGCD-265 (Glesatinib)....

Motesanib, also known as AMG-706, is the orally bioavailable multiple-receptor tyr...

Nintedanib, also known as BIBF 1120, is an orally bioavailable inhibitor of vascul...

NVP-BHG712, also known as BHG-712, is a EphB4 kinase inhibitor and BCR-ABL inhibit...

Orantinib, also known as TSU-68；SU6668, is an orally bioavailable receptor tyrosin...

OSI-930 is a selective thiophene-derived tyrosine kinase inhibitor with potential ...

Pazopanib is an approved drug, is a small molecule inhibitor of multiple protein t...

Pexmetinib, also known as ARRY-614, is an orally bioavailable small-molecule inhib...

PF-00337210

PF-00337210 is an orally available ATP-competitive inhibitor of the vascular endot...

R1530 is a pyrazolobenzodiazepine small molecule with potential antiangiogenesis a...

RAF-265 (CHIR-265)

CHIR-265 is an orally bioavailable small molecule with potential antineoplastic ac...

Rebastinib, also known as DCC-2036, is an orally bioavailable small-molecule inhib...

Semaxanib, also known as SU5416, is a quinolone derivative with potential antineop...

SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase i...

SKLB610 is a VEGFR inhibitor that potently suppresses human tumor angiogenesis. SK...

SSR128129E (SSR) is an potent FGFR inhibitor, which inhibits fibroblast growth fac...

SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascul...